Dimemorfan is a cough suppressant and expectorant medication used to treat a variety of chest and respiratory conditions. It works by targeting a specific receptor in the brain that reduces the activity of the coughing reflex. Dimemorfan is available in syrup and tablet form, and is typically taken every four to six hours. Common side effects of the medication include nausea, vomiting, headache, dizziness, and drowsiness.
Dimemorfan, also known as dimemorphan phosphate, is a cough suppressant medication belonging to the morphinan family. Here's a breakdown of its key points:
- Function: It works by directly targeting the cough center in the brain stem, effectively suppressing coughs.
- Popularity: Widely used in Japan, and also marketed in Spain and Italy. Not available in many other countries.
- Development: Developed by Yamanouchi Pharmaceutical (now Astellas Pharma) and introduced in Japan in 1975.
- Brand Names: Astomin, Dastosirr, Tusben
Comparison to other cough suppressants:
- Similarities: Dimemorfan is an analogue of dextromethorphan (DXM) and acts similarly, but with some key differences.
- Key Difference: Unlike DXM, dimemorfan has minimal effect on the NMDA receptor, which means it lacks the dissociative side effects and has lower abuse potential compared to DXM.
Additional Information:
- Side Effects: Minor side effects like nausea, drowsiness, and loss of appetite have been reported in less than 10% of patients.
- Safety Profile: Considered a non-narcotic cough suppressant with a low risk of dependence compared to opioid-based cough suppressants.
Important Note: If you have any questions or concerns about dimemorfan or cough suppressants in general, consult with a licensed physician for the best course of treatment.